» Articles » PMID: 10515405

Development of Wheezing in Patients with Cough Variant Asthma During an Increase in Airway Responsiveness

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 1999 Oct 9
PMID 10515405
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Two theories explaining the mechanism for the manifestation of cough without wheeze in patients with cough variant asthma (CVA) are either a higher wheezing threshold or a milder degree of airway hyperresponsiveness. A significant proportion of patients diagnosed as having CVA eventually develop wheezing. The aim of this study was to investigate whether this change in the manifestation of asthma was associated with a decrease in wheezing threshold and/or an increase in airway hyperresponsiveness. Thirty-six children (7-15 yrs) with CVA were prospectively studied for 4 yrs. Bronchial provocation tests with methacholine using the stepwise increasing concentration technique were performed annually to measure the provocative cumulative dose producing a 20% fall in forced expiratory volume in one second (PD20). Wheezing thresholds were additionally determined at the initiation of and the end of the study (development of wheezing, or after 4 yrs). Sixteen (Group 1) of 29 patients available for the follow-up developed clinical wheezing during the period; 13 patients (Group 2) stayed as CVA or their cough resolved. There was no significant change in wheezing thresholds from the initiation to the end of the study (Group 1: 40.9+/-8.2% versus 40.2+/-8.3%; Group 2: 41.4+/-7.1% versus 40.1+/-7.3%). Methacholine PD20 (geometric mean, range of 1 SD), expressed as breath unit (BU), significantly decreased in Group 1 patients as they developed wheezing (initial versus wheezing year: 60.8 BU, 29.2-126.5 versus 32.8 BU, 11.5-93.3; p<0.01), whereas the value did not change in Group 2 patients (initial versus after 4 yrs: 85.3 BU, 45.2-161.1 versus 84.3 BU, 39.7-179.1; NS). The results suggest that an increase in airway hyperresponsiveness, but not a decrease in wheezing threshold, may have a pathogenetic role in the development of wheezing during the course of cough variant asthma in childhood.

Citing Articles

Bibliometric Analysis of Cough Variant Asthma from 1993 to 2022.

Zhu Z, Wu J, Chen W, Luo F, Zhao X J Asthma Allergy. 2024; 17:517-537.

PMID: 38855058 PMC: 11162189. DOI: 10.2147/JAA.S452097.


WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation - .

Rouadi P, Idriss S, Bousquet J, Laidlaw T, Azar C, Al-Ahmad M World Allergy Organ J. 2021; 14(12):100618.

PMID: 34963794 PMC: 8666560. DOI: 10.1016/j.waojou.2021.100618.


Diagnostic Value of Fractional Exhaled Nitric Oxide and Small Airway Function in Differentiating Cough-Variant Asthma from Typical Asthma.

Wang Y, Zhao L, Chen F, Guo Y, Ma H, Han B Can Respir J. 2021; 2021:9954411.

PMID: 34457097 PMC: 8397554. DOI: 10.1155/2021/9954411.


Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of HuangQiXiXin Decoction on Cough Variant Asthma and Evidence-Based Medicine Approach Validation.

Xia Q, Liu M, Li H, Tian L, Qi J, Zhang Y Evid Based Complement Alternat Med. 2020; 2020:3829092.

PMID: 33178315 PMC: 7647767. DOI: 10.1155/2020/3829092.


Comparison of therapeutic effects of inhaled corticosteroids on three subtypes of cough variant asthma as classified by the impulse oscillometry system.

Sugawara H, Saito A, Yokoyama S, Tsunematsu K, Takahashi H Respir Res. 2019; 20(1):41.

PMID: 30808365 PMC: 6390374. DOI: 10.1186/s12931-019-1005-2.